Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims
暂无分享,去创建一个
Dana Goldman | Pinar Karaca-Mandic | P. Karaca-Mandic | A. Jena | D. Goldman | Anupam B Jena | Lesley Weaver | L. Weaver
[1] P. Christo,et al. The influence of prescription monitoring programs on chronic pain management. , 2009, Pain physician.
[2] Daniel M. Hartung,et al. Rates of Adverse Events of Long-Acting Opioids in a State Medicaid Program , 2007, The Annals of pharmacotherapy.
[3] Hassan Baxi,et al. Time series analysis of California's prescription monitoring program: impact on prescribing and multiple provider episodes. , 2012, The journal of pain : official journal of the American Pain Society.
[4] R. Cohen,et al. Medicare Advantage Chronic Special Needs Plan boosted primary care, reduced hospital use among diabetes patients. , 2012, Health affairs.
[5] K. Saunders,et al. Relationship of Opioid Use and Dosage Levels to Fractures in Older Chronic Pain Patients , 2010 .
[6] Lesley H Curtis,et al. Inappropriate prescribing for elderly Americans in a large outpatient population. , 2004, Archives of internal medicine.
[7] Michael J Smith,et al. Doctor and Pharmacy Shopping for Controlled Substances , 2012, Medical care.
[8] W. Ling,et al. Prescription opioid abuse, pain and addiction: clinical issues and implications. , 2011, Drug and alcohol review.
[9] Bradley C. Martin,et al. Trends in use of opioids for non-cancer pain conditions 2000–2005 in Commercial and Medicaid insurance plans: The TROUP study , 2008, PAIN.
[10] Wing Chow,et al. A Large Cohort Study from a Medication Dispensing Database in the US , 2012 .
[11] L. Leresche,et al. Age and gender trends in long-term opioid analgesic use for noncancer pain. , 2010, American journal of public health.
[12] A. Spinewine,et al. 2012 Updated Beers Criteria: Greater Applicability to Europe? , 2012, Journal of the American Geriatrics Society.
[13] Lisa M. Schwartz,et al. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000 , 2004, Pain.
[14] S. Fishman,et al. Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics. , 2010, Drug and alcohol dependence.
[15] D. Juurlink,et al. Facing up to the prescription opioid crisis , 2011, British medical journal.
[16] Sangho Moon,et al. Health care utilization among Medicare-Medicaid dual eligibles: a count data analysis , 2006, BMC public health.
[17] S. Davis,et al. Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. , 2010, American Journal of Preventive Medicine.
[18] S. Fishman,et al. An analysis of the number of multiple prescribers for opioids utilizing data from the California Prescription Monitoring Program , 2011, Pharmacoepidemiology and drug safety.
[19] Susan Okie,et al. A flood of opioids, a rising tide of deaths. , 2010, The New England journal of medicine.
[20] Ray Wang,et al. Hospital readmission rates in Medicare Advantage plans. , 2012, The American journal of managed care.
[21] N. Brennan,et al. Comparing quality of care in the Medicare program. , 2010, The American journal of managed care.
[22] Yongli Xi,et al. Increasing deaths from opioid analgesics in the United States , 2006, Pharmacoepidemiology and drug safety.
[23] P. Gallagher,et al. Inappropriate prescribing and adverse drug events in older people , 2009, BMC geriatrics.
[24] J. Berlin,et al. Characteristics of prescribers whose patients shop for opioids: results from a cohort study. , 2012, Journal of opioid management.
[25] Emily R. Hajjar,et al. Unnecessary Drug Use in Frail Older People at Hospital Discharge , 2005, Journal of the American Geriatrics Society.
[26] D. Webster,et al. Rethinking opioid prescribing to protect patient safety and public health. , 2012, JAMA.
[27] Leonard J Paulozzi,et al. Prescription drug monitoring programs and death rates from drug overdose. , 2011, Pain medicine.
[28] Jonathan N. Hawley,et al. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? , 2007, The American journal of geriatric pharmacotherapy.
[29] Meelee Kim,et al. Usefulness of prescription monitoring programs for surveillance—analysis of Schedule II opioid prescription data in Massachusetts, 1996–2006 , 2010, Pharmacoepidemiology and drug safety.
[30] O. Blin,et al. Impact of a prescription monitoring program on doctor‐shopping for high dosage buprenorphine , 2009, Pharmacoepidemiology and drug safety.
[31] S. Soumerai,et al. Racial disparities in access after regulatory surveillance of benzodiazepines. , 2006, Archives of internal medicine.
[32] B. Psaty,et al. Opioid Prescriptions for Chronic Pain and Overdose , 2010, Annals of Internal Medicine.
[33] M Soledad Cepeda,et al. Assessing Opioid Shopping Behaviour , 2012, Drug Safety.
[34] J. Rassen,et al. The comparative safety of analgesics in older adults with arthritis. , 2010, Archives of internal medicine.
[35] G. Pasternak,et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. , 2009, The journal of pain : official journal of the American Pain Society.
[36] Cathy Schoen,et al. Physician–Patient Communication About Prescription Medication Nonadherence: A 50-state Study of America’s Seniors , 2007, Journal of General Internal Medicine.
[37] T. Stürmer,et al. Opioid Analgesics and the Risk of Fractures in Older Adults with Arthritis , 2011, Journal of the American Geriatrics Society.
[38] B. Friedman,et al. Managed care and preventable hospitalization among Medicaid adults. , 2004, Health services research.
[39] J David Haddox,et al. Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data. , 2004, The American journal of managed care.
[40] L. Paulozzi,et al. Opioid analgesics and rates of fatal drug poisoning in the United States. , 2006, American journal of preventive medicine.
[41] Florence T. Bourgeois,et al. Adverse drug events in the outpatient setting: an 11‐year national analysis , 2010, Pharmacoepidemiology and drug safety.
[42] J. Cooper,et al. Polypharmacy in the aged. Practical solutions. , 1994, Drugs & aging.
[43] Leonard J. Paulozzi,et al. Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. , 2011, MMWR. Morbidity and mortality weekly report.